Xeris Biopharma Holdings (XERS)'s 30-day implied volatility (IV30) was 62.9% at the close on November 20, 2026, up from 32.9% the day before, against a 52-week range of 32.9% to 96.1%. Its 20-day historical volatility was 44.9%.
Data as of November 20, 2026.